Director, Us Federal Labs
Current- West area leader of the new Diasorin strategy focused on penetrating the US Federal Government.
- Developed and implemented Immunoassay strategy and execution for the federal government accounts
- Revenue growth of 2.5x. 3x install base.
- 2023 results: 194% YoY growth in Immuno. 180% YoY molecular